A single intravenous infusion of DMT, a fast-acting psychedelic compound found in the Amazonian brew ayahuasca, significantly ...

"In practice, we often maintain patients on antidepressants, but in order to do the most rigorous test of the efficacy of MST as a monotherapy, we needed to test it alone, without concurrent ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

A study comparing individuals with persistent depressive disorder to those with episodic major depressive disorder found that those with persistent depression had lower treatment expectations. These ...

Major depressive disorder is a debilitating condition that impacts around 5% of adults worldwide. While doctors commonly prescribe antidepressants to patients, it has several side effects and might ...

"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of Medicine at Mount Sinai has found that the serum of patients with major ...

Smartwatches may soon warn of depression relapse weeks in advance by detecting disrupted sleep and daily routines, offering a passive way to monitor mental health.

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...